CGNXCognex Corporation
Is the price fair?
A demanding price: priced for +15% a year vs +7% a year delivered, at the top of its own P/E range, and rich vs its sector.
Priced for ~15% a year FCF growth. The price demands more than its three-year revenue growth of 7% a year, priced for acceleration.
Expensive vs its own history: P/E 60.5 vs a 45.9 median over 41 quarters (+32% vs median).
Sector median 30.5× across 203 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What CGNX's price assumes
Cognex Corporation trades at 60.5× earnings against 38.2× for the median Scientific & Technical Instruments name, more expensive than its own group.
Trailing P/E · Scientific & Technical Instruments median 38.2 · 1.58× the median: the market pays up for this one
- Price / sales
- 11.1
Price / sales · today's price, fiscal year to Dec 31, 2025
- Free cash flow yield
- 2.4%
Free cash flow yield · Scientific & Technical Instruments median 4.0%
- Growth the price implies
- +15%
Growth the price implies · The price pays for +15% free cash flow growth a year for a decade; the business has delivered +12% a year over the last three.
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 7.42
- EV / EBITtoday's price, fiscal year to Dec 31, 2025
- 66.0
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 10.8
- Technology median P/E459 names
- 37.7
- Scientific & Technical Instruments median P/E18 names
- 38.2
- Free cash flow, trailing twelve months
- $268M
- Market capitalisation
- $11.1B
- 3-year revenue growth
- +6.9%
- 3-year free cash flow growth
- +12%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $40.02 |
| Its own P/E history, median | $47.73 |
| Its own P/E history, upper quartile | $59.45 |
| 52-week range | $34.70 – $71.55 |
| Today | $62.92 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Scientific & Technical Instruments
Ranks #8 of 12 by RyuScore